Results 111 to 120 of about 452,167 (205)

Gastroparesis-An Often-Overlooked Sign of Multiple Sclerosis: Case Report. [PDF]

Case Reports Immunol
Kukan B, Brown K, Chung M, Veselsky S, Ferrell J.   +4 more
europepmc   +1 more source

JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients [PDF]

, 2012
Roberta Mancuso, Marina Saresella, Ambra Hernis, Ivana Marventano, Cristian Ricci, Simone Agostini, Marco Rovaris, Domenico Caputo, Mario Clerici   +8 more
openalex   +1 more source

Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis. [PDF]

PLoS Comput Biol
Weatherley GR, Araujo RP, Dando SJ, Jenner AL.   +3 more
europepmc   +1 more source

RESULTS OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN REFRACTORY MULTIPLE SCLEROSIS: TWO CASE REPORTS

Ünsal Yılmaz, Muhammed Murati, Güler DELİBALTA, Serdar Bedii Omay, Mücahit Gür   +4 more
openalex   +1 more source

Managing reactivation of multiple sclerosis during treatment with natalizumab. [PDF]

Mult Scler
Lizak N, Sharmin S, Horáková D, Havrdova EK, Eichau S, van der Walt A, Butzkueven H, Lechner-Scott J, Buzzard K, Skibina O, Gerlach O, Prat A, Girard M, Duquette P, Alroughani R, Patti F, Grand'Maison F, Sá MJ, Aguera-Morales E, Hodgkinson S, Grammond P, Kuhle J, Yamout B, Khoury SJ, Ozakbas S, Csepany T, John N, Laureys G, Terzi M, Amato MP, Boz C, Al-Asmi A, Cartechini E, Gouider R, Mrabet S, Roos I, Kalincik T.   +36 more
europepmc   +1 more source

Multiple sclerosis and clostridium perfringens epsilon toxin: is there a relationship?

Huss, André, Bachhuber, Franziska, Feraudet-Tarisse, Cécile, Hiergeist, Andreas, Tumani, Hayrettin   +4 more
openalex   +1 more source

Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances. [PDF]

Int J Mol Sci
Kurilin V, Fisher M, Obleukhova I, Sennikov S.   +3 more
europepmc   +1 more source

A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis. [PDF]

Eur J Neurol
Maersk-Moller C, Pontieri L, Stilund MLM, Christensen JR, Storr LK, Hansen V, Schäfer J, Weglewski A, Romani KQ, Jensen HB, Illes Z, Papp V, Sejbaek T, Poulsen MB, Kant M, Torring CW, Sellebjerg F, Magyari M, DMSG Group.   +18 more
europepmc   +1 more source

Self-efficacy as a predictor of self-reported physical, cognitive, and social functioning in multiple sclerosis.

, 2013
Margaret M. Schmitt, Yael Goverover, John DeLuca, Nancy D. Chiaravalloti   +3 more
openalex   +1 more source

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis

, 2014
Claudio Gasperini, Serena Ruggieri, Carla Tortorella   +2 more
openalex   +2 more sources